Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xiaoying Luo
Loss of miR-638 in Vitro Promotes Cell Invasion and a Mesenchymal-Like Transition by Influencing SOX2 Expression in Colorectal Carcinoma Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Conservation and Reintroduction of Firmiana Danxiaensis, a Rare Tree Species Endemic to Southern China
Oryx
Evolution
Ecology
Nature
Systematics
Behavior
Landscape Conservation
Related publications
miR-125a-5p Inhibits Colorectal Cancer Cell Epithelial–mesenchymal Transition, Invasion and Migration by Targeting TAZ
OncoTargets and Therapy
Oncology
Pharmacology
ASPP1 Deficiency Promotes Epithelial-Mesenchymal Transition, Invasion and Metastasis in Colorectal Cancer
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Uc.416 + a Promotes Epithelial-To-Mesenchymal Transition Through miR-153 in Renal Cell Carcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
RIOK2 Is Negatively Regulated by miR‐4744 and Promotes Glioma Cell Migration/Invasion Through Epithelial‐mesenchymal Transition
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Loss of Trop2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Low Expression of microRNA-30c Promotes Invasion by Inducing Epithelial Mesenchymal Transition in Non-Small Cell Lung Cancer
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2
Cancer Management and Research
Oncology
Neuropilin-2 Expression Promotes TGF-β1-Mediated Epithelial to Mesenchymal Transition in Colorectal Cancer Cells
PLoS ONE
Multidisciplinary
miR-25 Promotes Hepatocellular Carcinoma Cell Growth, Migration and Invasion by Inhibiting RhoGDI1
Oncotarget
Oncology